Third European evidence-based consensus on diagnosis and management of ulcerative colitis. Part 1: definitions, diagnosis, extra-intestinal manifestations …

F Magro, P Gionchetti, R Eliakim… - Journal of Crohn's …, 2017 - academic.oup.com
1.2. Definitions Ulcerative colitis [UC] is a chronic inflammatory condition that causes
continuous mucosal inflammation of the colon, usually without granulomas on biopsy. It …

Systematic review: histological remission in inflammatory bowel disease. Is 'complete'remission the new treatment paradigm? An IOIBD initiative

RV Bryant, S Winer, T SPL… - Journal of Crohn's and …, 2014 - academic.oup.com
Background and aims: Advances in the medical management of inflammatory bowel
disease (IBD) have altered treatment targets. Endoscopic mucosal healing is associated …

ACG clinical guideline: management of Crohn's disease in adults

GR Lichtenstein, EV Loftus, KL Isaacs… - Official journal of the …, 2018 - journals.lww.com
Crohn's disease is an idiopathic inflammatory disorder of unknown etiology with genetic,
immunologic, and environmental influences. The incidence of Crohn's disease has steadily …

European evidence based consensus for endoscopy in inflammatory bowel disease

V Annese, M Daperno, MD Rutter… - Journal of Crohn's …, 2013 - academic.oup.com
Endoscopy plays an essential role in the diagnosis, management, prognosis, and
surveillance of inflammatory bowel disease (IBD), but surprisingly there are few available …

Beyond endoscopic mucosal healing in UC: histological remission better predicts corticosteroid use and hospitalisation over 6 years of follow-up

RV Bryant, DC Burger, J Delo, AJ Walsh, S Thomas… - Gut, 2016 - gut.bmj.com
Background Endoscopic mucosal healing is an established treatment target for UC, yet the
value of achieving histological remission remains unclear. Aims To evaluate histological …

Management of Crohn's disease in adults

GR Lichtenstein, SB Hanauer… - Official journal of the …, 2009 - journals.lww.com
Guidelines for clinical practice are intended to suggest preferable approaches to particular
medical problems as established by interpretation and collation of scientifically valid …

Tumor necrosis factor inhibitors for inflammatory bowel disease

OH Nielsen, MA Ainsworth - New England Journal of Medicine, 2013 - Mass Medical Soc
Tumor Necrosis Factor Inhibitors for Inflammatory Bowel Disease | New England Journal of
Medicine Skip to main content The New England Journal of Medicine homepage Advanced …

[HTML][HTML] Differential diagnosis in inflammatory bowel disease colitis: state of the art and future perspectives

GE Tontini, M Vecchi, L Pastorelli… - World journal of …, 2015 - ncbi.nlm.nih.gov
Distinction between Crohn's disease of the colon-rectum and ulcerative colitis or
inflammatory bowel disease (IBD) type unclassified can be of pivotal importance for a …

Treat to target: a proposed new paradigm for the management of Crohn's disease

G Bouguen, BG Levesque, BG Feagan… - Clinical …, 2015 - Elsevier
The traditional management of Crohn's disease, which is based on progressive, step-wise
treatment intensification with re-evaluation of response according to symptoms, does not …

One‐year clinical outcomes with biologics in Crohn's disease: transmural healing compared with mucosal or no healing

F Castiglione, N Imperatore, A Testa… - Alimentary …, 2019 - Wiley Online Library
Background While mucosal healing has been proved to predict relevant clinical outcomes in
Crohn's disease (CD), little is known about the long‐term significance of transmural healing …